Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lyn M Duncan

Showing results (101-110 of 123) with videos related to

Pageof 13
Sort By:
Cancer Research|February 18, 2010
An oncogenic role for ETV1 in melanomaJudit Jané-Valbuena, Hans R Widlund, Sven Perner, et al.
The Journal of Clinical Investigation|June 4, 2013
MicroRNA-mediated loss of ADAR1 in metastatic melanoma promotes tumor growthYael Nemlich, Eyal Greenberg, Rona Ortenberg, et al.
Journal of Cutaneous Pathology|March 22, 2019
Muir-Torre syndrome appropriate use criteria: Effect of patient age on appropriate use scores, Claudia I Vidal, Angela Sutton, et al.
The American Journal of Surgical Pathology|March 13, 2014
Histomorphologic assessment and interobserver diagnostic reproducibility of atypical spitzoid melanocytic neoplasms with long-term follow-upPedram Gerami, Klaus Busam, Alistair Cochran, et al.
Journal of Cutaneous Pathology|April 4, 2025
Shifts in Cutaneous Melanocytic Tumor Diagnostic Terminology: Melanocytoma, MPATH-Dx V2.0 and the WHO Skin5Lyn M Duncan, David E Elder, Michael W Piepkorn, et al.
Blood|August 25, 2021
Primary cytotoxic T-cell lymphomas harbor recurrent targetable alterations in the JAK-STAT pathwayKatie Lee, Mark G Evans, Lei Yang, et al.
Blood|February 5, 2005
WHO-EORTC classification for cutaneous lymphomasRein Willemze, Elaine S Jaffe, Günter Burg, et al.
Cancer|January 28, 2003
Cytotoxic/natural killer cell cutaneous lymphomas. Report of EORTC Cutaneous Lymphoma Task Force WorkshopMarco Santucci, Nicola Pimpinelli, Daniela Massi, et al.
The Journal of Clinical Investigation|April 16, 2013
MERTK receptor tyrosine kinase is a therapeutic target in melanomaJennifer Schlegel, Maria J Sambade, Susan Sather, et al.
Histopathology|November 20, 2025
WHO classification of skin tumours: key updates in the fifth editionGabrielle Goldman-Lévy, Raymond Barnhill, Boris C Bastian, et al.
Pageof 13

Showing results (101-110 of 123) with videos related to

Sort By:
Pageof 13
Cancer Research|February 18, 2010
An oncogenic role for ETV1 in melanomaJudit Jané-Valbuena, Hans R Widlund, Sven Perner, et al.
The Journal of Clinical Investigation|June 4, 2013
MicroRNA-mediated loss of ADAR1 in metastatic melanoma promotes tumor growthYael Nemlich, Eyal Greenberg, Rona Ortenberg, et al.
Journal of Cutaneous Pathology|March 22, 2019
Muir-Torre syndrome appropriate use criteria: Effect of patient age on appropriate use scores, Claudia I Vidal, Angela Sutton, et al.
The American Journal of Surgical Pathology|March 13, 2014
Histomorphologic assessment and interobserver diagnostic reproducibility of atypical spitzoid melanocytic neoplasms with long-term follow-upPedram Gerami, Klaus Busam, Alistair Cochran, et al.
Journal of Cutaneous Pathology|April 4, 2025
Shifts in Cutaneous Melanocytic Tumor Diagnostic Terminology: Melanocytoma, MPATH-Dx V2.0 and the WHO Skin5Lyn M Duncan, David E Elder, Michael W Piepkorn, et al.
Blood|August 25, 2021
Primary cytotoxic T-cell lymphomas harbor recurrent targetable alterations in the JAK-STAT pathwayKatie Lee, Mark G Evans, Lei Yang, et al.
Blood|February 5, 2005
WHO-EORTC classification for cutaneous lymphomasRein Willemze, Elaine S Jaffe, Günter Burg, et al.
Cancer|January 28, 2003
Cytotoxic/natural killer cell cutaneous lymphomas. Report of EORTC Cutaneous Lymphoma Task Force WorkshopMarco Santucci, Nicola Pimpinelli, Daniela Massi, et al.
The Journal of Clinical Investigation|April 16, 2013
MERTK receptor tyrosine kinase is a therapeutic target in melanomaJennifer Schlegel, Maria J Sambade, Susan Sather, et al.
Histopathology|November 20, 2025
WHO classification of skin tumours: key updates in the fifth editionGabrielle Goldman-Lévy, Raymond Barnhill, Boris C Bastian, et al.
Pageof 13